Annual jab for HIV protection passes trial hurdle
- Wednesday, March 12, 2025, 7:01
- Health, Sports
- Add a comment
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
About the Author
adminasapcorp has written 39363 stories on this site.